Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 24Gastrointestinal 22Other hematologic neoplasm 19Tumor-Agnostic 14Thoracic 12Gynecologic 12Lymphoid 10Genitourinary 10CNS 7Other solid neoplasm 6Plasma cell 5Head & Neck 5Sarcoma 4Myeloid 3Dermatologic 3Endocrine 2Other 1NET 1

Conditions

Weight Loss 1Obesity 1Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Palliative Care × Endocrine × Clear all
NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02938897 2016-10-19

Telenutrition Weight Loss Study for Men

West Virginia University

Phase NA Completed
60 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡